On July 28, Unilever PLC rose 8.11% in regular trading, trading at $66.55/share, with turnover of $41.85 million. The surge was driven by the company's half-year earnings release, which comprehensively exceeded market expectations.

Unilever reported H1 adjusted earnings per share of $1.88, up 8.05% year-over-year, on revenue of $29.902 billion. Underlying sales growth reached 4.8% in the first half, accelerating to 5.8% in Q2 — well above analyst estimates of 4.3%. Q2 turnover came in at 13.05 billion euros versus 12.57 billion euros a year earlier. Volume growth was particularly robust at 5.5%, marking the strongest pace in over a decade. The company also raised its full-year sales growth guidance to the 4%-6% range, with H2 growth of 4%-5% expected to be driven by pricing.

The strong results reinforced market confidence in Unilever's strategic pivot toward health and personal care businesses, which is delivering growth well above most peers in the consumer goods sector.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)